Compounded Medication – Prescription Only
This product is a compounded topical medication formulated as a cream and dispensed only pursuant to a valid prescription issued by a licensed healthcare provider. In compounding practice, topical combination formulations containing prescription pharmaceutical ingredients may be prescribed when a provider determines that individualized formulation, concentration, or excipient selection is clinically appropriate for a specific patient. This product is not available for self-selection and may be dispensed only following provider authorization. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or quality. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription. This page provides general, non-therapeutic information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, physiologic effect, or expected clinical outcomes.
General Scientific Information (Non-Therapeutic)
The active pharmaceutical ingredients in this formulation are referenced in scientific literature for their molecular structures and pharmacologic classifications. Discussion of ingredient classes or biochemical properties is provided solely for general scientific context. No claims are made regarding safety, effectiveness, topical response, vascular activity, sensory effects, sexual function, or suitability for any particular condition.
Contraindications
Arousal Cream should not be used in individuals who have a known hypersensitivity or allergy to sildenafil, methylxanthines, ergoloid derivatives, pentoxifylline, arginine, or any component of the compounded formulation; have experienced prior adverse reactions to topical preparations containing similar active pharmaceutical ingredients; or have skin conditions that may be adversely affected by topical application as determined by the prescribing healthcare provider. Use in pregnant or breastfeeding individuals should occur only if a licensed healthcare provider determines that potential risks and benefits have been carefully evaluated.
Warnings and Precautions
Topical absorption of active pharmaceutical ingredients may occur. Caution is advised in individuals with cardiovascular conditions, blood pressure disorders, or those using medications that may interact with phosphodiesterase inhibitors or vasoactive agents. Avoid application to broken, irritated, or inflamed skin unless specifically directed by a licensed healthcare provider. Patients should wash hands after application and avoid contact with eyes or mucous membranes. Patients should inform their healthcare provider of all medical conditions, medications, and allergies prior to using this compounded formulation.
Potential Side Effects
Reported side effects associated with topical compounded formulations containing vasoactive or pharmacologically active ingredients may include local skin irritation, redness, itching, burning sensation, or rash; headache; dizziness; flushing; or transient changes in blood pressure. Serious adverse reactions are uncommon but may occur. Patients should seek immediate medical attention if they experience signs of a severe allergic reaction, systemic symptoms, or unexpected cardiovascular effects.